Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (371-380 of 496) with videos related to

Pageof 50
Sort By:
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationHonglin Song, Ed Dicks, Susan J Ramus, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Lancet (London, England)|December 29, 2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialIan J Jacobs, Usha Menon, Andy Ryan, et al.
Circulation|May 14, 2017
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization AnalysisCaroline E Dale, Ghazaleh Fatemifar, Tom M Palmer, et al.
Journal of the National Cancer Institute|August 29, 2015
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J Ramus, Honglin Song, Ed Dicks, et al.
Cancer Research|April 13, 2011
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancerJennifer Permuth-Wey, Donghwa Kim, Ya-Yu Tsai, et al.
Pageof 50

Showing results (371-380 of 496) with videos related to

Sort By:
Pageof 50
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationHonglin Song, Ed Dicks, Susan J Ramus, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Lancet (London, England)|December 29, 2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialIan J Jacobs, Usha Menon, Andy Ryan, et al.
Circulation|May 14, 2017
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization AnalysisCaroline E Dale, Ghazaleh Fatemifar, Tom M Palmer, et al.
Journal of the National Cancer Institute|August 29, 2015
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J Ramus, Honglin Song, Ed Dicks, et al.
Cancer Research|April 13, 2011
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancerJennifer Permuth-Wey, Donghwa Kim, Ya-Yu Tsai, et al.
Pageof 50